SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600132-16-000019
Filing Date
2016-03-01
Accepted
2016-03-01 16:03:55
Documents
1
Period of Report
2016-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_145686622405191.html 4  
1 FORM 4 wf-form4_145686622405191.xml 4 3888
  Complete submission text file 0001600132-16-000019.txt   5318
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 EAST 42ND STREET, SUITE 1160 NEW YORK NY 10165
Business Address
Tenenbaum Fabian (Reporting) CIK: 0001641300 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 161473195